AzTrials
AzTrials

Anxiety Disorders and SymptomsPTLNCT03437317

Emotional Perceptual Training as a Treatment for Social Anxiety: Behavioral and Neural Evidence.

A study testing Perceptual Retraining and Gender Discrimination in people with Anxiety Disorders and Symptoms and Social Anxiety Disorder, run by Florida State University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Perceptual Training Study is a series of studies performed with the purpose of identifying a potential avenue for treatment of mood disorders, particularly anxiety-based mood disorders. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
What is being tested?
Perceptual Retraining and Gender Discrimination
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
154 participants
Where
No sites listed yet
Study dates
1 Nov 2014to 15 Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Right-handed
  • Normal or corrected-to-normal vision

Who cannot join

  • History of a diagnosed neurological or Diagnostic and Statistical Manual of Mental Disorders - IV Axis I disorder
  • Currently taking prescribed psychoactive drugs, including anti-depressants or anxiolytics.
  • Having electrically, magnetically, or mechanically activated implants (e.g. cardiac pacemakers), due to incompatibility with MRI and MEG systems.
  • Pregnancy or suspected pregnancy

About this study

The Perceptual Training Study is a series of studies performed with the purpose of identifying a potential avenue for treatment of mood disorders, particularly anxiety-based mood disorders. The underlying theme is that neural representations may be threat-oriented, and may also be generalized to non-threatening cues by means of similarity to threatening representations. These may result in anxiety symptoms from innocuous cues. The idea behind the perceptual training is to create a divorce between the threat representations and cues which should be considered non-threatening, enhancing perceptual acuity and potentially reducing anxiety symptoms.

Being tested
Perceptual Retraining, Gender Discrimination
Keywords
Social Anxiety, Threat processing, Magnetoencephalography (MEG)
Medical subject headings
Anxiety Disorders, Phobia, Social

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Perceptual RetrainingBehavioural

    Participants viewed faces varying in their expression of anger and were asked to identify if the face was angry or neutral via button press. Participants were provided with feedback if their categorization of the face as neutral or angry was correct. Each participant was assigned 4 levels of angry faces based on their decision point of anger detection in faces. Faces were selected based on the closest existing anger morph to the category boundary; for example, a decision point of 40% anger was closest to the 38% anger face, and so the faces used would have been 17%, 31%, 45%, and 59% anger. For this example, responses of "neutral" to the 31% angry face would be marked as correct, whereas a similar response to the 45% angry face would be incorrect, as it was above their decision point.

  • Gender DiscriminationBehavioural

    Participants viewed faces varying in their expression of anger and were asked to identify if the face was male or female via button press.

Study groups in NCT03437317
Study groupRoleWhat they receive
Active - MEGExperimentalParticipants completed 1 session of 8 Perceptual Retraining blocks following an instructional presentation.
Receives: Behavioral: Perceptual Retraining
Control - MEGSham comparatorParticipants completed 1 session of 8 blocks of Gender Discrimination Task.
Receives: Behavioral: Gender Discrimination
Active - 3 Behavior/EEGExperimentalParticipants completed 3 sessions of Perceptual Retraining following an instructional presentation. The first session included 6 blocks of perceptual training, and the second session included 12 blocks of perceptual training. No perceptual training was performed in session 3. Sessions were spaced approximately 7 days apart, with a minimum of 3 days and a maximum of 14 days apart.
Receives: Behavioral: Perceptual Retraining
Active - 1 Behavior/MEGExperimentalParticipants completed 1 session of 6 Perceptual Retraining blocks following an instructional presentation.
Receives: Behavioral: Perceptual Retraining
Control - 3 Behavior/MEGSham comparatorParticipants completed 3 sessions of a Gender Discrimination Task. The first session included 6 blocks of gender discrimination task, and the second session included 12 blocks of the gender discrimination task. No gender discrimination task was performed in session 3. Sessions were spaced approximately 7 days apart, with a minimum of 3 days and a maximum of 14 days apart.
Receives: Behavioral: Gender Discrimination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Behavioral Evidence for Categorical Perception Changes

    Participants will be asked to respond if they detected anger in faces varying in their levels of anger expression. This task is used to determine a perceptual bias for threat/anger in faces that is related to increases in social anxiety symptoms, and assess for improvements in the categorization of angry vs. neutral faces. that align with modulations of neural responses (MEG and EEG evidence) indexing perceptual processing of the faces following perceptual retraining.

    Measured: Baseline to Study Completion (14 to 28 Days)

  2. Neural Evidence for Categorical Perception Changes

    Neural activity will be recorded using EEG and MEG to measure neural processes underpinning categorical perception of anger in faces. Changes in this neural perceptual index will be assessed following perceptual retraining to provide a neural mechanism underpinning behavioral improvements in perceptual categorization and subsequent reductions in anxiety.

    Measured: Baseline to Study Completion (14 to 28 Days)

Secondary outcomes (2)
  1. Social Anxiety Symptoms - Social Phobia Scale

    Change in social anxiety symptomatology through perceptual retraining

    Measured: Baseline to Study Completion (14 to 28 Days)

  2. Social Anxiety Symptoms - Liebowitz Social Anxiety Scale

    Change in social anxiety symptomatology through perceptual retraining

    Measured: Baseline to Study Completion (14 to 28 Days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2018
  2. Study start1 Nov 2014
  3. Primary completion15 Dec 2016
  4. Study completion15 Dec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomly assigned to either an active training group or a control group. The active participants completed 8 blocks of a perceptual training task, while the control group performed 8 blocks of a gender discrimination task that received the perceptual retraining protocol
Masking
Single blind
Who is masked
Participant
Enrolment
154 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03437317
Sponsor's protocol ID
PTL-2017.21521
Acronym
PTL
Status last verified
Feb 2018
First submitted
6 Feb 2018
Last updated
19 Feb 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Perceptual Retraining and Gender Discrimination in people with Anxiety Disorders and Symptoms and Social Anxiety Disorder, run by Florida State University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Behavioral Evidence for Categorical Perception Changes (time frame: Baseline to Study Completion (14 to 28 Days)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in